PlumBot: Bot: Creating new article from JSON

2026-03-10T13:40:31Z

Bot: Creating new article from JSON

New page

💊 '''Prescription drug coverage''' is a component of [[Definition:Health insurance | health insurance]] that pays for or subsidizes the cost of medications prescribed by a licensed healthcare provider, representing one of the most heavily utilized and cost-sensitive [[Definition:Benefit | benefits]] within any medical plan. In the insurance industry, this coverage appears across [[Definition:Group health insurance | group health plans]], [[Definition:Individual health insurance | individual market policies]], [[Definition:Medicare | Medicare]] Part D programs, and [[Definition:Self-insured plan | self-insured employer arrangements]], each with its own regulatory framework and cost-containment architecture. Insurers and [[Definition:Pharmacy benefit manager (PBM) | pharmacy benefit managers (PBMs)]] collaborate closely to structure this benefit, balancing member access with the financial sustainability of the overall [[Definition:Insurance plan | plan]].

⚙️ The mechanics typically revolve around a [[Definition:Formulary | formulary]] — a tiered list of approved drugs organized by cost and clinical preference. Generic medications usually sit on the lowest tier with the smallest [[Definition:Copayment | copayment]], while specialty biologics may occupy the highest tier with significant [[Definition:Coinsurance | coinsurance]] requirements or [[Definition:Prior authorization | prior authorization]] hurdles. PBMs negotiate [[Definition:Rebate | rebates]] with pharmaceutical manufacturers and manage the claims adjudication process at the pharmacy counter, often in real time. Insurers set the [[Definition:Deductible | deductible]] and [[Definition:Out-of-pocket maximum | out-of-pocket maximum]] structures that determine how costs are shared between the plan and the member. [[Definition:Actuarial analysis | Actuarial teams]] model drug utilization trends, pipeline medications approaching patent expiry, and the expected impact of newly approved therapies to price the benefit accurately during [[Definition:Underwriting | underwriting]] and [[Definition:Rate filing | rate filing]] cycles.

📈 Rising pharmaceutical costs make this coverage a persistent pressure point for [[Definition:Insurance carrier | carriers]], employers, and regulators. Specialty drugs now account for a disproportionate share of total pharmacy spend, and the introduction of gene therapies and cell-based treatments has forced insurers to rethink traditional benefit designs. [[Definition:Stop-loss insurance | Stop-loss carriers]] underwriting [[Definition:Employer self-funded plan | self-funded employer plans]] increasingly scrutinize pharmacy exposure, sometimes adding [[Definition:Lasering | lasering]] provisions or [[Definition:Specific stop-loss | specific deductible]] adjustments for members on high-cost drug regimens. Within [[Definition:Insurtech | insurtech]], data analytics platforms are emerging that help carriers predict pharmacy cost trajectories, identify waste, and design value-based contracting arrangements with manufacturers — making prescription drug coverage an active frontier for both underwriting innovation and operational efficiency.

'''Related concepts'''
{{Div col|colwidth=20em}}
* [[Definition:Pharmacy benefit manager (PBM)]]
* [[Definition:Formulary]]
* [[Definition:Health insurance]]
* [[Definition:Prior authorization]]
* [[Definition:Stop-loss insurance]]
* [[Definition:Medicare Part D]]
{{Div col end}}

Definition:Prescription drug coverage - Revision history

PlumBot: Bot: Creating new article from JSON